Parties involved in valsartan cancer lawsuits have put forward 28 potential early test cases to serve as bellwether trials to represent at least 600 claims the recalled hypertension drugs contained high levels of NDMA.…
A federal judge has cleared the way for valsartan NDMA lawsuits to proceed against manufacturers of the tainted hypertension drugs.…
A new position paper warns doctors need to more carefully check women for hypertension, which is often mistaken for menopause in middle-aged women.…
One lot of a drug meant to induce paralysis during anesthesia is being recalled after it was discovered some bottles were accidentally labeled as a blood pressure medication.…
A new study questions whether hypertension drugs have a negative impact on patients with COVID-19 infections.…
The findings of a new study indicate pregnant women who suffer high blood pressure or preeclampsia may suffer memory loss later in life.…
Two former district judges have been appointed as Special Masters in valsartan litigation, with hopes they will bring the parties to a settlement agreement.…
Valsartan proceedings will continue throughout 2021, with the first trials unlikely to be held before 2022.…
A new study’s finding suggest women with preeclampsia could take vitamin D supplements to decrease their child’s risk of later developing high blood pressure and related health problems, like heart disease.…
Parties in valsartan litigation have dueling arguments over the validity of the litigation as defendants seek to have the Master Complaint dismissed.…
